Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Recurrence × DNA Methylation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Leukemia 9 Leukemia, Myeloid, Acute 5 Congenital Abnormalities 5 Uterine Cervical Neoplasms 3 Lung Neoplasms 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Erythroblastic, Acute 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Squamous Intraepithelial Lesions 2 Sarcoma 2 Colonic Neoplasms 2 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Melanoma 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Kidney Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Surgical Procedures, Operative 7 Liver Transplantation 4 Lenalidomide 4 Liquid Biopsy 3 Blood Specimen Collection 3 pomalidomide 2 gilteritinib 2 Therapeutics 2 Proteasome Inhibitors 2 Observation 2 Neoadjuvant Therapy 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Immunotherapy, Adoptive 2 Immunoconjugates 2 High-Throughput Nucleotide Sequencing 2 DNA, Mitochondrial 2 Brentuximab Vedotin 2 Antibodies, Monoclonal 2 Antibodies, Bispecific 2 Amplified Fragment Length Polymorphism Analysis 2 trametinib 1 romidepsin 1 nedaplatin 1 lenvatinib 1 fluoroazomycin arabinoside 1 exemestane 1 elotuzumab 1 dacomitinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡